2026 Q1 -tulosraportti
49 päivää sitten
‧22 min
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 12.5. | ||
2025 Q4 -tulosraportti 5.2. | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 16.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·12 t sittenSo right now there are twice as many buyers as sellers. So the sellers are in control, stop selling cheaply. Are you scared
If one has positioned oneself anyway and intends to see it through - then the price until approval is irrelevant. Then, in the end, it will be management's negotiation skills, demand data, and price points (read future sales) that become price-driving. I'm staying in because I don't want to be left out when the approval is announced.
·18 t sittenDoes anyone know if we can expect information about gk from FDA by July 3rd at the latest?
Yes exactly, in 90% of cases the FDA responds before or on the PDUFA date. To my knowledge, the ambition is 100%, but they only succeed in 90% of cases, to my knowledge. I.e. in at most 106 hours. Since Friday is a holiday in the USA, it should be at the latest in 82 hours, it could easily be in 75 hours. But it can also be before or after. Personally, I think they will respond on time due to the relatively low complexity, but one must assess that oneself.
·3 päivää sittenNothing negative from the company or FDA, exciting yes.Yes, FDA responds in 90% of cases at the latest on the PDUFA date, either before or on the day. Roughly estimated, people believe there is an 85-92% probability of approval. As for the probability of an early partnership, I don't think one can put a meaningful probability on it. They sound positive, and there must be interested parties and also at a price that is above (in my world far above) the current share price, at worst then at minimum current value, and then the "bet" is free. It's never entirely certain with investments, no matter what one invests in, but regarding approval, the odds are very good, the return, however, is unknown. I am also nervous. It has turned out to be a really bad stock, again and again. There are continuously many Swedish companies that rise 100-400% without any particularly big reason, even with large volume, but here where there is actually something real behind it (Orviglance), there is just no interest.
·3 päivää sitten1 week left, but an answer can come at any time. Exciting, very exciting. :)- ·24.6.I feel a slight flutter in my stomach when one considers that PDUFA is already next Friday. So an announcement can come anytime from now on.Many thanks for your input in the debate. It is appreciated. I do not expect a 200% increase on an FDA approval. But to say that it is not important is probably not right. If the application is rejected, what is the company and the stock then worth? I have previously held shares in companies where an approval was awaited, but where the application was rejected. Then a partnership agreement is not worth much. I hope and believe in an approval next week and then I hope for a good partnership agreement or possibly a sale of the company. It will be exciting in any case.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
49 päivää sitten
‧22 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·12 t sittenSo right now there are twice as many buyers as sellers. So the sellers are in control, stop selling cheaply. Are you scaredIf one has positioned oneself anyway and intends to see it through - then the price until approval is irrelevant. Then, in the end, it will be management's negotiation skills, demand data, and price points (read future sales) that become price-driving. I'm staying in because I don't want to be left out when the approval is announced.
- ·18 t sittenDoes anyone know if we can expect information about gk from FDA by July 3rd at the latest?Yes exactly, in 90% of cases the FDA responds before or on the PDUFA date. To my knowledge, the ambition is 100%, but they only succeed in 90% of cases, to my knowledge. I.e. in at most 106 hours. Since Friday is a holiday in the USA, it should be at the latest in 82 hours, it could easily be in 75 hours. But it can also be before or after. Personally, I think they will respond on time due to the relatively low complexity, but one must assess that oneself.
- ·3 päivää sittenNothing negative from the company or FDA, exciting yes.Yes, FDA responds in 90% of cases at the latest on the PDUFA date, either before or on the day. Roughly estimated, people believe there is an 85-92% probability of approval. As for the probability of an early partnership, I don't think one can put a meaningful probability on it. They sound positive, and there must be interested parties and also at a price that is above (in my world far above) the current share price, at worst then at minimum current value, and then the "bet" is free. It's never entirely certain with investments, no matter what one invests in, but regarding approval, the odds are very good, the return, however, is unknown. I am also nervous. It has turned out to be a really bad stock, again and again. There are continuously many Swedish companies that rise 100-400% without any particularly big reason, even with large volume, but here where there is actually something real behind it (Orviglance), there is just no interest.
- ·3 päivää sitten1 week left, but an answer can come at any time. Exciting, very exciting. :)
- ·24.6.I feel a slight flutter in my stomach when one considers that PDUFA is already next Friday. So an announcement can come anytime from now on.Many thanks for your input in the debate. It is appreciated. I do not expect a 200% increase on an FDA approval. But to say that it is not important is probably not right. If the application is rejected, what is the company and the stock then worth? I have previously held shares in companies where an approval was awaited, but where the application was rejected. Then a partnership agreement is not worth much. I hope and believe in an approval next week and then I hope for a good partnership agreement or possibly a sale of the company. It will be exciting in any case.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 12.5. | ||
2025 Q4 -tulosraportti 5.2. | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 16.5.2025 |
2026 Q1 -tulosraportti
49 päivää sitten
‧22 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 12.5. | ||
2025 Q4 -tulosraportti 5.2. | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 16.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·12 t sittenSo right now there are twice as many buyers as sellers. So the sellers are in control, stop selling cheaply. Are you scaredIf one has positioned oneself anyway and intends to see it through - then the price until approval is irrelevant. Then, in the end, it will be management's negotiation skills, demand data, and price points (read future sales) that become price-driving. I'm staying in because I don't want to be left out when the approval is announced.
- ·18 t sittenDoes anyone know if we can expect information about gk from FDA by July 3rd at the latest?Yes exactly, in 90% of cases the FDA responds before or on the PDUFA date. To my knowledge, the ambition is 100%, but they only succeed in 90% of cases, to my knowledge. I.e. in at most 106 hours. Since Friday is a holiday in the USA, it should be at the latest in 82 hours, it could easily be in 75 hours. But it can also be before or after. Personally, I think they will respond on time due to the relatively low complexity, but one must assess that oneself.
- ·3 päivää sittenNothing negative from the company or FDA, exciting yes.Yes, FDA responds in 90% of cases at the latest on the PDUFA date, either before or on the day. Roughly estimated, people believe there is an 85-92% probability of approval. As for the probability of an early partnership, I don't think one can put a meaningful probability on it. They sound positive, and there must be interested parties and also at a price that is above (in my world far above) the current share price, at worst then at minimum current value, and then the "bet" is free. It's never entirely certain with investments, no matter what one invests in, but regarding approval, the odds are very good, the return, however, is unknown. I am also nervous. It has turned out to be a really bad stock, again and again. There are continuously many Swedish companies that rise 100-400% without any particularly big reason, even with large volume, but here where there is actually something real behind it (Orviglance), there is just no interest.
- ·3 päivää sitten1 week left, but an answer can come at any time. Exciting, very exciting. :)
- ·24.6.I feel a slight flutter in my stomach when one considers that PDUFA is already next Friday. So an announcement can come anytime from now on.Many thanks for your input in the debate. It is appreciated. I do not expect a 200% increase on an FDA approval. But to say that it is not important is probably not right. If the application is rejected, what is the company and the stock then worth? I have previously held shares in companies where an approval was awaited, but where the application was rejected. Then a partnership agreement is not worth much. I hope and believe in an approval next week and then I hope for a good partnership agreement or possibly a sale of the company. It will be exciting in any case.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt